{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:33:34Z","timestamp":1760142814788,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biopha.2021.112330","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:31:57Z","timestamp":1634689917000},"page":"112330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["JKST6, a novel multikinase modulator of the BCR-ABL1\/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia"],"prefix":"10.1016","volume":"144","author":[{"given":"Haid\u00e9e","family":"Aranda-Tav\u00edo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlota","family":"Recio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Mart\u00edn-Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Guerra-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeray","family":"Brito-Casillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Junco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Gandullo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"McNaughton-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atanasio","family":"Pandiella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Amesty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Est\u00e9vez-Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro","family":"Fern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112330_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2021.112330_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematol."},{"key":"10.1016\/j.biopha.2021.112330_bib3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1056\/NEJM198810133191506","article-title":"The molecular genetics of philadelphia chromosome\u2013positive leukemias","volume":"319","author":"Kurzrock","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112330_bib4","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1038\/s41388-019-0752-3","article-title":"Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology","volume":"38","author":"Recio","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2021.112330_bib5","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4161\/cc.25116","article-title":"Adding a new facet to STAT5 in CML multitasking for leukemic cells","volume":"12","author":"Warsch","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopha.2021.112330_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","article-title":"The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML","volume":"20","author":"Vetrie","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2021.112330_bib7","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/bph.12183","article-title":"Targeting survival pathways in chronic myeloid leukaemia stem cells","volume":"169","author":"Sinclair","year":"2013","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112330_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000468","article-title":"Chronic myeloid leukemia in 2020","volume":"4","author":"Hehlmann","year":"2020","journal-title":"HemaSphere"},{"key":"10.1016\/j.biopha.2021.112330_bib9","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2021.112330_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1200\/JCO.2013.52.9123","article-title":"Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia","volume":"32","author":"Dusetzina","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2021.112330_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01055-9","article-title":"Third-line therapy for chronic myeloid leukemia: current status and future directions","volume":"14","author":"Cortes","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2021.112330_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/107327480901600204","article-title":"Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia","volume":"16","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.biopha.2021.112330_bib13","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/1535-7163.MCT-09-0168","article-title":"Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated withresistance to BCR-ABL inhibitors","volume":"8","author":"Grosso","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2021.112330_bib14","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1182\/blood-2010-03-276477","article-title":"Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis","volume":"117","author":"Sun","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2021.112330_bib15","doi-asserted-by":"crossref","unstructured":"M. Brehme, O. Hantschel, J. Colinge, I. Kaupe, M. Planyavsky, T. K\u00f6cher, K. Mechtler, K.L. Bennett, G. Superti-Furga, Charting the molecular network of the drug target Bcr-Abl, Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 7414\u20137419. https:\/\/doi.org\/10.1073\/pnas.0900653106.","DOI":"10.1073\/pnas.0900653106"},{"key":"10.1016\/j.biopha.2021.112330_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01672-1","article-title":"Proteolysis targeting chimeras (PROTACs) in cancer therapy","volume":"39","author":"Oca\u00f1a","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2021.112330_bib17","first-page":"1","article-title":"Future approaches for treating chronic myeloid leukemia: crispr therapy","volume":"10","author":"Vuelta","year":"2021"},{"key":"10.1016\/j.biopha.2021.112330_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.00939","article-title":"BCR-ABL independent mechanisms of resistance in chronic myeloid leukemia","volume":"9","author":"Loscocco","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2021.112330_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/cbdd.13141","article-title":"Naphthoquinones: a continuing source for discovery of therapeutic antineoplastic agents","volume":"91","author":"Qiu","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"issue":"2020)","key":"10.1016\/j.biopha.2021.112330_bib20","article-title":"Anticancer effects and mechanisms of action of plumbagin: review of research advances","author":"Yin","year":"2020","journal-title":"Biomed. Res. Int"},{"key":"10.1016\/j.biopha.2021.112330_bib21","doi-asserted-by":"crossref","first-page":"29679","DOI":"10.18632\/oncotarget.11425","article-title":"CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia","volume":"8","author":"Guerra","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2021.112330_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01546","article-title":"A novel naphthoquinone-coumarin hybrid that inhibits BCR-ABL1-STAT5 oncogenic pathway and reduces survival in imatinib-resistant chronic myelogenous leukemia cells","volume":"9","author":"Mart\u00edn-Rodr\u00edguez","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112330_bib23","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.bmc.2004.01.051","article-title":"2-Pyrones possessing antimicrobial and cytotoxic activities","volume":"12","author":"Fairlamb","year":"2004","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.biopha.2021.112330_bib24","first-page":"1","article-title":"Two new pyrone derivatives from the mangrove-derived endophytic fungus Aspergillus sydowii #2B","volume":"0","author":"Wang","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2021.112330_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13659-017-0136-8","article-title":"\u03b1-Pyrone derivatives from a Streptomyces strain resensitize tamoxifen resistance in breast cancer cells","volume":"7","author":"Yang","year":"2017","journal-title":"Nat. Prod. Bioprospect"},{"key":"10.1016\/j.biopha.2021.112330_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.211","article-title":"Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy","volume":"4","author":"Estrada","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2021.112330_bib27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1158\/1541-7786.MCR-10-0356","article-title":"MYC in chronic myeloid leukemia: Induction of aberrant DNA synthesis and association with poor response to imatinib","volume":"9","author":"Albajar","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2021.112330_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2021.112330_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1741-7007-10-29","article-title":"Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation","volume":"10","author":"Vinci","year":"2012","journal-title":"BMC Biol."},{"key":"10.1016\/j.biopha.2021.112330_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.biopha.2021.112330_bib31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2021.112330_bib32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the chou-talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2021.112330_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00401402","article-title":"Irwin 1968 (1).pdf","volume":"13","author":"Irwin","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.biopha.2021.112330_bib34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-5521(01)00056-4","article-title":"Proteasome inhibitors: from research tools to drug candidates","volume":"8","author":"Kisselev","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biopha.2021.112330_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/sj.onc.1200885","article-title":"Tyrosine 207 in CRKL is the BCR\/ABL phosphorylation site","volume":"14","author":"De Jong","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2021.112330_bib36","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance","volume":"96","author":"Mahon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2021.112330_bib37","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.leu.2404227","article-title":"Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis","volume":"20","author":"Zheng","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2021.112330_bib38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug-target residence time and its implications for lead optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2021.112330_bib39","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1039\/C7CS00220C","article-title":"Structure-based design of targeted covalent inhibitors","volume":"47","author":"Lonsdale","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2021.112330_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1039\/b416651p","article-title":"2-pyrone natural products and mimetics: Isolation, characterisation and biological activity","volume":"22","author":"McGlacken","year":"2005","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biopha.2021.112330_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ddtec.2017.03.002","article-title":"The production of 3D tumor spheroids for cancer drug discovery","volume":"23","author":"Sant","year":"2017","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.biopha.2021.112330_bib42","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-118648","article-title":"Metabolism of acute myeloid leukemia cell lines alters with passage in 2D culture and remains stable in 3D","volume":"132","author":"Zemenides","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2021.112330_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104463","article-title":"Pharmacological properties and derivatives of shikonin\u2014a review in recent years","volume":"149","author":"Guo","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.112330_bib44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2021.112330_bib45","first-page":"779","article-title":"A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle","volume":"75","author":"Welch","year":"1993","journal-title":"Natl. Libr. Med."},{"key":"10.1016\/j.biopha.2021.112330_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/cells8020145","article-title":"C\/EBP\u03b2 Is a transcriptional regulator of Wee1 at the G2\/M phase of the cell cycle","volume":"8","author":"Lee","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2021.112330_bib47","doi-asserted-by":"crossref","first-page":"18414","DOI":"10.3390\/molecules191118414","article-title":"Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid Leukemia - the possibility to target several kinases through inhibition of the various CDC25 isoforms","volume":"19","author":"Brenner","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.112330_bib48","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1128\/MCB.25.13.5725-5737.2005","article-title":"Akt\/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2\/M transition","volume":"25","author":"Katayama","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112330_bib49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s004120050256","article-title":"Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation","volume":"106","author":"Hendzel","year":"1997","journal-title":"Chromosom"},{"key":"10.1016\/j.biopha.2021.112330_bib50","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.leukres.2009.08.017","article-title":"Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo","volume":"34","author":"Xu","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.biopha.2021.112330_bib51","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/MCB.21.13.4129-4139.2001","article-title":"ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1","volume":"21","author":"Zhao","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2021.112330_bib52","first-page":"433","article-title":"Tricyclic pyrone analogs: a new class of microtubule-disrupting anticancer drugs effective against murine leukemia cells in vitro","volume":"12","author":"Newell","year":"1998","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2021.112330_bib53","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.3892\/or.2017.5627","article-title":"Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi-1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP","volume":"37","author":"Kong","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2021.112330_bib54","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s10495-006-7787-y","article-title":"Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents","volume":"11","author":"Vrana","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.biopha.2021.112330_bib55","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1074\/jbc.TM117.000117","article-title":"Ubiquitin signaling and autophagy","volume":"293","author":"Grumati","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.112330_bib56","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1182\/blood-2006-02-005579","article-title":"Activation of a novel Bcr\/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells","volume":"109","author":"Bartholomeusz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2021.112330_bib57","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3892\/mmr.2017.6965","article-title":"Shikonin suppresses proliferation and induces apoptosis in human leukemia NB4 cells through modulation of MAPKs and c-Myc","volume":"16","author":"Shan","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2021.112330_bib58","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2003-09-3126","article-title":"Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3","volume":"103","author":"Peltola","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2021.112330_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103450","article-title":"The synthetic flavanone 6-methoxy-2-(naphthalen-1-yl)chroman-4-one induces apoptosis and activation of the MAPK pathway in human U-937 leukaemia cells","volume":"94","author":"Saavedra","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2021.112330_bib60","series-title":"Prog. Mol. Biol. Transl. Sci.","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-396456-4.00007-9","article-title":"The role of protein phosphorylation in therapy resistance and disease progression in chronic myelogenous leukemia","author":"Juan","year":"2012"},{"key":"10.1016\/j.biopha.2021.112330_bib61","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O\u2019Reilly","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2021.112330_bib62","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.V101.2.690","article-title":"BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571","volume":"101","author":"Donato","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2021.112330_bib63","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"O\u2019Hare","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2021.112330_bib64","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1073\/pnas.0601638103","article-title":"Crystal structure of the SOCS2\u2013elongin C\u2013elongin B complex defines a prototypical SOCS box ubiquitin ligase","volume":"103","author":"Bullock","year":"2006","journal-title":"Proc. Natl. Acad. Scii U. S. A."},{"issue":"5","key":"10.1016\/j.biopha.2021.112330_bib65","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V99.5.1766","article-title":"Overexpression of SOCS-2 in advanced stages of chronicmyeloid leukemia: possible inadequacy of a negative feedback mechanism","volume":"99","author":"Schultheis","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2021.112330_bib66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cytogfr.2008.08.006","article-title":"The many faces of the SOCS box","volume":"19","author":"Piessevaux","year":"2008","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:40:59Z","timestamp":1760100059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221011148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":66,"alternative-id":["S0753332221011148"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112330","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JKST6, a novel multikinase modulator of the BCR-ABL1\/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112330"}}